Correspondence 0001628280-23-000670 from Pear Therapeutics, Inc. (CIK 0001835567)
Pear Therapeutics, Inc. (CIK 0001835567)
Date: Jan. 6, 2023 · CIK: 0001835567 · Accession: 0001628280-23-000670
AI Filing Summary & Sentiment
File numbers found in text: 333-269097
Show Raw Text
CORRESP 1 filename1.htm Document Pear Therapeutics, Inc. 200 State Street, 13th Floor Boston, MA 02109 January 6, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Pear Therapeutics, Inc. Registration Statement on Form S-3 File No. 333-269097 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Pear Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-269097) (the “Registration Statement”), so that it may become effective at 4:00 pm Eastern time on January 10, 2023, or as soon thereafter as practicable, or at such other time as the Registrant or its outside counsel, Foley Hoag LLP, requests by telephone that such Registration Statement be declared effective. Please feel free to direct any questions or comments concerning this request to Stacie S. Aarestad, Esq. of Foley Hoag LLP at (617) 832-1108. [Remainder of this page intentionally left blank] Very truly yours, PEAR THERAPEUTICS, INC. By: /s/ Corey McCann Name: Corey McCann Title: President and Chief Executive Officer [Signature Page to Pear Therapeutics, Inc. Acceleration Request]